Erwinia chrysanthemi L-asparaginase E63Q +S254N mutation + L-Aspartic acid
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
Erwinia chrysanthemi L-asparaginase E63Q +S254N mutation + L-Aspartic acid
应用场景：
创建时间：
2023-09-27
相关数据集
Fuplatin: An Efficient and Low-Toxic Dual-Prodrug
As FDA-approved chemotherapeutic agents, cisplatin, oxaliplatin, and 5-fluorouracil are widely used in clinic but limited by severe side-effects. To ameliorate their respective defects, a series of “d
NIAID Data Ecosystem70
Synergistic anticancer activity of resveratrol-loaded polymeric nanoparticles and sunitinib in colorectal cancer treatment
The development of novel and effective treatment strategies, particularly through drug combinations, can significantly enhance therapeutic outcomes. This study explores the innovative combination of
DataCite Commons2025-06-01 更新50
Water Mediated Synthesis and Anticancer Evaluation of Oxindole-embedded Chalcone Hybrids: Insights from Computational Studies and A549 Cell Line Assay
This study presents a novel water-mediated synthesis method for oxindole functionalized chalcone derivatives, which have various therapeutic applications, particularly in cancer treatment. The newly s
Figshare2025-03-09 更新60
Design, Synthesis, and Biological Investigation of Epothilone B Analogues Featuring Lactone, Lactam, and Carbocyclic Macrocycles, Epoxide, Aziridine, and 1,1-Difluorocyclopropane and Other Fluorine Residues
Despite previous studies within the epothilone field, only one member of this compound family, ixabepilone, made it to approval for clinical use. Recent advances in organic synthesis and medicinal che
NIAID Data Ecosystem60
